Skip to main content

BIO International Convention 2020

Novosanis will be present at the BIO International Convention as part of the Belgian delegate via Flanders Investment and Trade. The congress takes place in San Diego, from 8 to 11 June. Our CEO (Vanessa Vankerckhoven) and our CTO (Koen Beyers) can be found at the Belgian Pavilion and look forward to meeting you there.

They are excited to tell you more about our unique urine capturing device Colli-Pee, and can’t wait to showcase the latest Colli-Pee volume variants and its possible applications. Learn more on our preservatives that allow for optimal stabilization, storage and shipment of urine samples.

Disclaimer

Novosanis is a wholly owned subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology. The Colli-Pee® family, the heart of the company, allows volumetric and standardized collection of first-void urine. The platform consists of variants capturing a range of urine volumes for different application purposes. Urine collection through the Colli-Pee® device is easy, comfortable, and more accurate than a regular urine cup. First-void urine has shown to improve detection of infectious diseases, including sexually transmitted infections as well as for some cancers applications. The Colli-Pee® device enables immediate mixing of the first-void urine sample with a preservative, improving stability of the urine specimen. Novosanis markets its products worldwide and has a global customer base.